The Business Times
business-time-50
GARAGE
·
SUBSCRIBERS

MiRXES eyes fuss-free early cancer tests; road ahead not easy

Local startup, which is heading towards a public listing, is doubling down on its acquisition strategy after a US$77m funding round

google-preferred-sourceAdd BT as a preferred source
Published Thu, Nov 18, 2021 · 09:50 PM

    Singapore

    IMAGINE if early-stage cancer testing was as fuss-free as taking a Covid PCR test or a blood test.

    Homegrown startup MiRXES is hoping to bring such "liquid" cancer tests into our homes in about 5 to 10 years' time. If this dream pans out, a simple blood test could be able to detect all types of cancers at an early stage - when it is easier to treat and possibly cure.

    StartupsA*StarM&A

    TRENDING NOW

    As household size is hardly growing, is there a need to build super-large landed homes?

    Think twice about rebuilding that old landed property into a super-big house to max out GFA

    Trading under the symbol SPCX, SpaceX has picked a handful of brokerage firms to distribute shares in the IPO to retail customers in the US.

    SpaceX’s US$1.75 trillion IPO: How retail investors, including those in Singapore, can buy shares

    Source of wealth establishment processes are typically the most time-intensive elements in onboarding ultra-high-net-worth clients.

    Battle for Asia’s ultra-rich: ‘Singapore can’t afford to keep losing clients to Dubai, Hong Kong’

    Fears of the AI rally overheating have led to tech stocks taking a hit globally.

    Tech rout sweeps Asia as AI rally jitters spark sell-off

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More